SCHEMBL5067374

SCHEMBL5067374

CCCCC[C@@H](O)C(=O)O

nearest known ligand 0.95

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.95
FFAR1 O14842 2/20 0.95
MAPT P10636 1/20 0.56
LCK P06239 1/20 0.56
PPARD Q03181 1/20 0.56
ZDHHC20 Q5W0Z9 1/20 0.56
ZDHHC2 Q9UIJ5 1/20 0.56
FFAR4 Q5NUL3 1/20 0.52
ACE2 Q9BYF1 1/20 0.52
GRIK1 P39086 1/20 0.48
SLC1A2 P43004 1/20 0.48
SLC1A1 P43005 1/20 0.48
GRIK2 Q13002 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13897852 1.00 GPR84 (0.95) GPR84FFAR1MAPTLCKPPARD
SCHEMBL44151 1.00 GPR84 (0.95) GPR84FFAR1MAPTLCKPPARD
SCHEMBL337352 0.98 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL4757199 0.98 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL525377 0.98 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2933185 0.98 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL525619 0.98 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL22842 0.98 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2709599 0.98 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD
SCHEMBL525700 0.98 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6165695-A None JP disclosed
US-11208435-B2 Verticilide enantiomer and methods of inhibiting cardiac ryanodine receptor-mediated intracellular calcium release VANDERBILT UNIVERSITY (US) 2021-12-28 US disclosed
US-20200262872-A1 VERTICILIDE ENANTIOMER AND METHODS OF INHIBITING CARDIAC RYANODINE RECEPTOR-MEDIATED INTRACELLULAR CALCIUM RELEASE VANDERBILT UNIVERSITY 2020-08-20 US disclosed
CN-104540845-B Novel cyclic depsipeptide derivative and pest control agent containing same 明治制果药业株式会社 2018-01-26 CN disclosed
US-20150038333-A1 PLANT PROTECTIVE COMPOSITION CONTAINING ALPHA-HYDROXY ACIDS HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENT -RUN FÜR GESUNDHEIT UND (DE) 2015-02-05 US disclosed
EP-2736331-A1 PLANT PROTECTIVE COMPOSITION CONTAINING ALPHA-HYDROXY ACIDS Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2014-06-04 EP disclosed
WO-2013014245-A1 PLANT PROTECTIVE COMPOSITION CONTAINING ALPHA-HYDROXY ACIDS HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2013-01-31 WO disclosed
US-20080261286-A1 Methods for producing optically active alpha-hydroxy amides DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2008-10-23 US disclosed
US-20050202545-A1 Methods for producing optically active alpha-hydroxy amides DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-15 US disclosed
EP-0920852-B1 Keratin fiber strengthening agent and method for strengthening keratin fiber TAKASAGO PERFUMERY CO LTD (JP) 2005-06-01 EP disclosed
US-6379659-B1 APPLYING (2S,3R)-2-ACYLAMINOALKANE-1,3-DIOL TO FIBER TAKASAGO INTERNATIONAL CORPORATION (JP) 2002-04-30 US disclosed
EP-0920852-A2 Keratin fiber strengthening agent and method for strengthening keratin fiber Takasago International Corporation (JP) 1999-06-09 EP disclosed
JP-H06165695-A PRODUCTION OF OPTICALLY ACTIVE 2-HYDROXYARYLACETIC ACID AND ITS DERIVATIVE SHOWA DENKO KK 1994-06-14 JP disclosed
US-4307112-A 9-Deoxy-9A-methylene isosteres of PGI2 and process for their preparation FARMITALIA CARLO ERBA S.P.A. (IT) 1981-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11208435-B2 Verticilide enantiomer and methods of inhibiting cardiac ryanodine receptor-mediated intracellular calcium release RYR2, RYR1, ATP2A1 GPR84 320/4885FFAR1 168/4885MAPT 3465/4885
US-20150038333-A1 PLANT PROTECTIVE COMPOSITION CONTAINING ALPHA-HYDROXY ACIDS HAO1, HAAO, HAO2 GPR84 2235/4885FFAR1 197/4885MAPT 3568/4885
US-20200262872-A1 VERTICILIDE ENANTIOMER AND METHODS OF INHIBITING CARDIAC RYANODINE RECEPTOR-MEDIATED INTRACELLULAR CALCIUM RELEASE RYR2, RYR1, ATP2A1 GPR84 320/4885FFAR1 168/4885MAPT 3465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.